Sidroga Reizhustentee
Sidroga Reizhustentee is a medicine authorised by Swissmedic under authorisation number 58488. The authorisation holder is Uriach Switzerland AG. The medicinal product code is Herbal medicines and the dispensing category is E: Supplied in any retail outlet without specialist advice, for example glucose tablets or certain care products. First authorisation was granted on 04 October 2007 and the authorisation is valid without a time limit. ATC code R02AX places the medicine in the group Throat preparations.
| Authorisation number | 58488 |
|---|---|
| Name | Sidroga Reizhustentee |
| Full name | Sidroga Reizhustentee, Arzneitee |
| Authorisation holder | Uriach Switzerland AG |
| Medicinal product code | Herbal medicines |
| Dispensing category | E · General sale |
| ATC code | R02AX |
| First authorisation | 04 October 2007 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Sidroga Reizhustentee, Arzneitee | E | 04 October 2007 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 20 x 0,9 | g | R02AX | 12.03.2. | E |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Sidroga Reizhustentee authorised in Switzerland?
Yes. Sidroga Reizhustentee is authorised by Swissmedic under authorisation number 58488, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Sidroga Reizhustentee have?
Sidroga Reizhustentee is in dispensing category E. Supplied in any retail outlet without specialist advice, for example glucose tablets or certain care products.
Who is the authorisation holder of Sidroga Reizhustentee?
The authorisation holder is Uriach Switzerland AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.